• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD RESONANCE STENT SET; FAD STENT, URETERAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD RESONANCE STENT SET; FAD STENT, URETERAL Back to Search Results
Catalog Number RMS-060022-R
Device Problems Fracture (1260); Difficult to Remove (1528); Use of Device Problem (1670)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/23/2020
Event Type  Injury  
Manufacturer Narrative
Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Event Description
Per rep - (b)(6) 2020 - the stents had been in-dwelling for 12 months.The stents were encrusted so badly that they had to try 5 fr catheters, dual lumen catheters and a rigid cystoscope to dilate.Lastly they had to balloon dilate to remove the stents with flexible graspers.The balloon dilation of the ureters successfully removed the stents.The occluded wire of the second stent snapped and the stent turned into a slinky but was successfully removed.They did not have consent from the patient's guardian for percutaneous techniques.General questions for all complaints: what are the current storage conditions? are the stents stored in their boxes? unkr, implant facility not known.Did the device make patient contact? yes.Once the device comes in contact with the patient, request the following for 3 previously mentioned prefixes: did anything have to be removed from the patient? yes.If yes, from what part of the body and what instrument was used to remove it? kidney and ureter, flexible graspers.Current storage conditions.Unkr, implant facility not known.Why was the stent removed? (exchange? or other issue?) -exchange.What was the length of the indwell time? 12 months.Did the user attempt to attach the stent to the inserter before or after wire guide insertion? n/a.What wire guide did they use? hydrophylic wire did they attempt to attach the tapered end of the stent to the inserter? n/a.Was this device assembled outside the body? n/a.Did the device come with a pigtail straightener? n/a.If yes, was the pigtail straightener used? n/a.Request the following should the complaint be regarding difficulty with the hydrophilic coating (wire guide): n/a.Should the event involve metallic resonance (rms) stents, request the following: was the stent stored in strong light (e.G.In a pyxis maching) or in direct sunlight? unkr, implant facility not known.Was there difficulty advancing the stent to the target location? n/a.How long was the stent in-dwelling? 12 months.What was used to remove the stent? flexible grasper.How often was the stent checked during the in-dwelling time? physician did not know.What method was used? unkr.Was the patient using calcium supplementation? unkr.Was force required to remove the stent? yes, a little bit.Was encrustation evident on the stent? yes, a lot.What is the source of the extrinsic compression? pt anatomy.If caused by a tumor, what is the tumor type? no tumor.What is the stage of the tumor? n/a.Per rep - 15oct2020 - can it please be confirmed what exact date the stents were placed, it just says 12 months prior? stents were placed (b)(6) 2019.Also how often was the patient monitored within this 12 month indwell period and by what methods please? patient had a couple ct scans for urinary tract infections, but due to covid the 6 month change was delayed to 12 months due to patient caregiver¿s decision.What is the patient's condition now? (b)(6) has not heard from the patient and expects them to be doing well.It is mentioned "they did not have consent from the patient's guardian for percutaneous techniques." how is the patient's condition managed after the stent removal? percutaneous consent wasn¿t provided at the time of the extraction procedure.However, following the stent extraction consent was obtained.The patient was then hospitalized overnight and perc¿ed the next morning for neph tube placement.Did any unintended section of the device remain inside the patient¿s body? no.If yes, please describe.Was the patient hospitalized or was there prolonged hospitalization? no.Did the patient require any additional procedures due to this occurrence? no.If yes, please describe.This new file was created to capture the second stent where the stent wire snapped.A sperate file is capturing the difficult removal of the first stent.
 
Manufacturer Narrative
Device evaluation: the rms-060022-r device of an unknown lot involved in this complaint was not available for evaluation.With the information provided, a document-based investigation was conducted.As the lot number of the complaint stents are unknown, a review of the relevant manufacturing records cannot be conducted.However, prior to distribution all rms-060022-r devices are subject to visual a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.It should be noted that the instructions for use (ifu0020-18) states the following: ¿patients should be checked at regular intervals utilizing techniques such as abdominal x-ray (kub film).Patients using calcium supplements must be removed if encrustation hampers drainage¿.Instructions of use also mention: "the stent must not remain indwelling more than 12 (twelve) months.If patient's status permits, the stent may be replaced with a new stent".The instructions of use also warn for potential adverse events "potential adverse events associated with indwelling ureteral stents include: stent encrustation" there is sufficient evidence to suggest the user did not follow the ifu.Per the event notes placed (b)(6) 2019, removed (b)(6) 2020.A definitive root cause could be attributed exceeded indwell period per event notes- placed (b)(6) 2019, removed (b)(6) 2020.It should be noted as per the customer input there was a lot of encrustation evident on the stent, it could be possible this contributed to the snapped wire.Note the patient was monitored during stent indwell patient had a couple ct scans for urinary tract infections, but due to covid the 6 month change was delayed to 12 months due to patient caregiver¿s decision.Summary: the complaint is confirmed based on customer testimony.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Event Description
Supplemental report is being submitted due to the completion of the investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESONANCE STENT SET
Type of Device
FAD STENT, URETERAL
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
aisling hassett
o halloran road
national technology park
limerick 
MDR Report Key10718197
MDR Text Key216662267
Report Number3001845648-2020-00808
Device Sequence Number1
Product Code FAD
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K063742
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRMS-060022-R
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date09/23/2020
Event Location Hospital
Initial Date Manufacturer Received 09/23/2020
Initial Date FDA Received10/22/2020
Supplement Dates Manufacturer Received09/23/2020
Supplement Dates FDA Received04/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age27 YR
Patient SexMale
-
-